Colon Adenoma and Cancer Cells Aberrantly Express the Leukocyte-Associated Sialoglycoprotein CD43
- 18 September 1997
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 238 (2) , 612-616
- https://doi.org/10.1006/bbrc.1997.7334
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Characterization of a CD43/Leukosialin-mediated Pathway for Inducing Apoptosis in Human T-Lymphoblastoid CellsJournal of Biological Chemistry, 1996
- Negative regulation of T-cell adhesion and activation by CD43Nature, 1995
- MEM‐59 monoclonal antibody detects a CD43 epitope involved in lymphocyte activationEuropean Journal of Immunology, 1995
- Disregulation of leukosialin (CD43, Ly48, sialophorin) expression in the B-cell lineage of transgenic mice increases splenic B-cell number and survival.Proceedings of the National Academy of Sciences, 1995
- CD43, the major sialoglycoprotein of human leukocytes, is proteolytically cleaved from the surface of stimulated lymphocytes and granulocytes.Proceedings of the National Academy of Sciences, 1993
- CD43 interferes with T-lymphocyte adhesion.Proceedings of the National Academy of Sciences, 1992
- Leukosialin, a major O-glycan-containing sialoglycoprotein defining leukocyte differentiation and malignancyGlycobiology, 1991
- Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome.Proceedings of the National Academy of Sciences, 1989
- Characterization of cDNAs encoding human leukosialin and localization of the leukosialin gene to chromosome 16.Proceedings of the National Academy of Sciences, 1989
- Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome.The Journal of Experimental Medicine, 1984